A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Bayer's booth presents regenerative agriculture products during ... "We think the economic resilience and the plans that we've seen from the government particularly on low carbon economy and rural ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

as management claimed that the drug showed an efficacy signal in female patients. Following the news, shares of Neumora hit an all-time low of $1.83. The latest announcement failed to impress ...

Bayer's booth presents regenerative agriculture ... and the plans that we've seen from the government particularly on low carbon economy and rural development show a lot of promise for the future ...

And there are certain odd habits that usually indicate a person has a low IQ, as their patterns of behavior reflect how they see and process the world and their place within it. It's important to ...

A new study has experts beaming with hope as it shows teen drug use at a record low, but they admit confusion as to why the trend is happening and how to ensure it continues. The annual national ...

Additionally, the U.S. has also adopted key technologies such as Energy efficiency, industrial electrification, low-carbon fuels, feedstocks, and energy sources (LCFFES), and carbon capture, ...

Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $4.86 and last traded at $4.88, with a volume of ...